Quality assurance in surgical trials of arteriovenous grafts for haemodialysis: protocol for a systematic review.

Dialysis End stage renal failure Protocols & guidelines VASCULAR SURGERY

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
07 07 2023
Historique:
medline: 10 7 2023
pubmed: 8 7 2023
entrez: 7 7 2023
Statut: epublish

Résumé

Decisions regarding the optimal vascular access for haemodialysis patients are becoming increasingly complex, and the provision of vascular access is open to variations in systems of care as well as surgical experience and practice. Two main surgical options are recognised: arteriovenous fistula and arteriovenous graft (AVG). All recommendations regarding AVG are based on a limited number of randomised controlled trials (RCTs). It is essential that when considering an RCT of a surgical procedure, an appropriate definition of quality assurance (QA) is made for both the new approach and the comparator, otherwise replication of results or implementation into clinical practice may differ from published results. The aim of this systematic review will be to assess the methodological quality of RCT involving AVG, and the QA measures implemented in delivering interventions in these trials. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines will be followed. A systematic search will be performed of the MEDLINE, Embase and Cochrane databases to identify relevant literature. Studies will be selected by title and abstract review, followed by a full-text review using inclusion and exclusion criteria. Data collected will pertain to generic measures of QA, credentialing of investigators, procedural standardisation and performance monitoring. Trial methodology will be compared against a standardised template developed by a multinational, multispecialty review body with experience in vascular access. A narrative approach will be taken to synthesise and report data. Ethical approval is not required as it is a protocol for a systematic review. Findings will be disseminated through peer-reviewed publications and conference presentations, with the ultimate aim of providing recommendations for future RCT of AVG design.

Identifiants

pubmed: 37419647
pii: bmjopen-2023-071646
doi: 10.1136/bmjopen-2023-071646
pmc: PMC10335504
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e071646

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ. 2002 Jun 15;324(7351):1448-51
pubmed: 12065273
J Vasc Access. 2023 Feb 27;:11297298231151365
pubmed: 36847168
Ann Surg. 2019 Feb;269(2):211-220
pubmed: 29697448
J Vasc Surg. 2008 Feb;47(2):395-401
pubmed: 18155872
Ann Surg. 2010 Mar;251(3):409-16
pubmed: 20142732
BMJ. 2017 Jul 20;358:j2998
pubmed: 28729459
Ann Intern Med. 2008 Feb 19;148(4):W60-6
pubmed: 18283201
J Vasc Access. 2013 Apr-Jun;14(2):111-5
pubmed: 23080334
J Am Soc Nephrol. 2005 Jan;16(1):201-9
pubmed: 15563567
J Vasc Access. 2017 Mar 21;18(2):126-131
pubmed: 28165579
Am J Kidney Dis. 2018 Apr;71(4):469-478
pubmed: 29198387
Clin Trials. 2017 Apr;14(2):211-218
pubmed: 28135839
Lancet. 2009 Sep 26;374(9695):1105-12
pubmed: 19782876
BMJ Open. 2019 Mar 1;9(3):e026209
pubmed: 30826769
Lancet. 2013 Jan 12;381(9861):91-2
pubmed: 23305999
Br J Surg. 2004 Jan;91(1):6-16
pubmed: 14716788
Am J Kidney Dis. 2020 Apr;75(4 Suppl 2):S1-S164
pubmed: 32778223
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
J Vasc Surg. 2011 Dec;54(6):1713-9
pubmed: 21803519
J Vasc Surg. 2017 Apr;65(4):1089-1103.e1
pubmed: 28222990
Gynecol Oncol. 2020 Jun;157(3):570-571
pubmed: 32334828
Eur J Vasc Endovasc Surg. 2018 Jun;55(6):757-818
pubmed: 29730128
Ann Surg. 2014 Aug;260(2):220-9
pubmed: 24743623
Hemodial Int. 2020 Apr;24(2):182-187
pubmed: 32052592
Eur J Surg Oncol. 2021 Apr;47(4):748-756
pubmed: 33059943
Eur J Surg Oncol. 2016 Aug;42(8):1115-22
pubmed: 27241924
J Vasc Surg. 2017 Mar;65(3):766-774
pubmed: 28236919
J Vasc Surg. 2005 Sep;42(3):481-6; discussions 487
pubmed: 16171591

Auteurs

Ben Edgar (B)

Department of Renal Surgery and Transplantation, Queen Elizabeth University Hospital, Glasgow, UK benjamin.edgar@nhs.scot.
School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.

David B Kingsmore (DB)

Department of Renal Surgery and Transplantation, Queen Elizabeth University Hospital, Glasgow, UK.
School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
Department of Vascular Surgery, Queen Elizabeth University Hospital, Glasgow, UK.

Emma Aitken (E)

Department of Renal Surgery and Transplantation, Queen Elizabeth University Hospital, Glasgow, UK.
School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.

Francis Calder (F)

Renal & Transplant Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Marco Franchin (M)

Department of Vascular Surgery, University of Insubria, Varese, Italy.

Colin Geddes (C)

Department of Nephrology, Queen Elizabeth University Hospital, Glasgow, UK.

Nick Inston (N)

Renal and Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Andrew Jackson (A)

Department of Renal Surgery and Transplantation, Queen Elizabeth University Hospital, Glasgow, UK.

Rob G Jones (RG)

Interventional Radiology, Queen Elizabeth Hospital, Birmingham, UK.

Nikolaos Karydis (N)

Department of General and Transplant Surgery, University of Patras, Patra, Greece.

Ram Kasthuri (R)

Department of Interventional Radiology, Queen Elizabeth University Hospital, Glasgow, UK.

Gaspar Mestres (G)

Department of Vascular Surgery, University of Barcelona, Barcelona, Spain.

Georgios Papadakis (G)

Renal & Transplant Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Rajesh Sivaprakasam (R)

Renal Transplantation, The Royal London Hospital, London, UK.

Mike Stephens (M)

Dialysis Access Team, University Hospital of Wales, Cardiff, UK.

Karen Stevenson (K)

Department of Renal Surgery and Transplantation, Queen Elizabeth University Hospital, Glasgow, UK.

Callum Stove (C)

Department of Interventional Radiology, Queen Elizabeth University Hospital, Glasgow, UK.

Lazslo Szabo (L)

Dialysis Access Team, University Hospital of Wales, Cardiff, UK.

Peter Thomson (P)

Department of Nephrology, Queen Elizabeth University Hospital, Glasgow, UK.

Matteo Tozzi (M)

Department of Vascular Surgery, University of Insubria, Varese, Italy.

Richard D White (RD)

Department of Interventional Radiology, University Hospital of Wales, Cardiff, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH